CRISPR Therapeutics AG
Long
Updated

CRSP, run up to earnings possible

218
RR: 4.85
Target: 33.5%, 21d
Price has been downward since the share offering announcement. Run up to ER is possible.
Trade closed: stop reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.